Smoking Cessation in the Surgical Patient
This American College of Surgeons Division of Education Surgical Smoking Cessation in the Surgical Patient program is for surgical practitioners to detail the effects of nicotine and smoking on surgical outcomes, the benefits of counseling and pharmacotherapy, the appropriate codes and reimbursement benefits for smoking cessation counseling, and resources for surgeons and patients.
- Identify the prevalence of tobacco consumption and its relationship to mortality and health care costs.
- Describe the risks and complications associated with smoking for surgical patients.
- Explain the types of smoking cessation methods and resources that are effective for surgical patients.
- Construct effective methods that can be applied in your practice to support preoperative smoking cessation.
- Determine the essential elements for coding and documentation to support reimbursement.
- The Impact of Smoking on Surgical Outcomes
- Smoking Cessation Interventions
- Counseling Reimbursement and Coding
- Course Evaluation
- CME Credit
- Practicing surgeons
- Professional health care providers
If you have any questions about this course, please contact email@example.com.
For technical assistance, please contact firstname.lastname@example.org.
Faculty and Disclosures
Nancy Strand, MPH, RN
Frederick Greene, MD, FACS
In accordance with the ACCME’s Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. Therefore, it is mandatory that both the program planning committee and speakers complete disclosure forms. Members of the program committee were required to disclose all financial relationships and speakers were required to disclose any financial relationship as it pertains to the content of the presentations. The ACCME defines a ‘commercial interest’ as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.” It does not consider providers of clinical service directly to patients to be commercial interests. The ACCME considers “relevant” financial relationships as financial transactions (in any amount) that may create a conflict of interest and occur within the 12 months preceding the time that the individual is being asked to assume a role controlling content of the educational activity.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the presentation. The planning committee members and speakers were contacted and the conflicts listed below have been managed to our satisfaction. However, if you perceive a bias, please advise us of the circumstances on the evaluation form.
Please note we have advised the speakers that it is their responsibility to disclose at the start of their presentation if they will be describing the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage.
The requirement for disclosure is not intended to imply any impropriety of such relationships, but simply to identify such relationships through full disclosure, and to allow the audience to form its own judgments regarding the presentation.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Completion